Aurinia Pharmaceuticals Inc - Common Shares (AUPH) earnings
AUPH earnings moved a median of -0.28% by the close. Quarterly and annual AUPH reports and results, each read against the price at its own news timestamp. Back to the AUPH overview →
16 measured AUPH earnings events.
Where these AUPH earnings landedvs 16 measured AUPH earnings reactions
| Middle 50% of AUPH earnings reactions | -3.56% to +1.94% |
|---|---|
| Median reaction (to close) | -0.28% |
| Measured reactions | 16 |
Point-in-time · zero look-ahead
Half of the 16 AUPH earnings events with a measured close landed between -3.56% and +1.94%; 44% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Aurinia Pharmaceuticals For: Jun 30 | SEC filing · Form 10-Q | -1.17% | +1.25% | |
| Form 10-Q Aurinia Pharmaceuticals For: Mar 31 | SEC filing · Form 10-Q | -0.25% | -6.54% | |
| Form 10-K Aurinia Pharmaceuticals For: Dec 31 | SEC filing · Form 10-K | -0.98% | -5.93% | |
| Form 10-Q Aurinia Pharmaceuticals For: Sep 30 | SEC filing · Form 10-Q | +12.89% | +5.70% | |
| Form 10-Q Aurinia Pharmaceuticals For: Jun 30 | SEC filing · Form 10-Q | +0.69% | -2.17% | |
| Aurinia Pharmaceuticals to Release Second Quarter 2025 Financial and Operational Results on July 31, 2025 | Press release | +0.82% | +3.74% | |
| Form 10-Q Aurinia Pharmaceuticals For: Mar 31 | SEC filing · Form 10-Q | -0.31% | -0.37% | |
| Aurinia Pharmaceuticals to Release First Quarter 2025 Financial and Operational Results on May 12, 2025 | Press release | +0.24% | +0.85% | |
| Form 10-K Aurinia Pharmaceuticals For: Dec 31 | SEC filing · Form 10-K | -13.65% | -2.33% | |
| Form 10-Q Aurinia Pharmaceuticals For: Sep 30 | SEC filing · Form 10-Q | +2.81% | +6.38% | |
| Form 10-Q Aurinia Pharmaceuticals For: Jun 30 | SEC filing · Form 10-Q | -0.78% | -2.77% | |
| Aurinia Pharmaceuticals Reports First Quarter 2024 Financial and Operational Results | Press release | -3.35% | -8.98% | |
| Form 10-Q Aurinia Pharmaceuticals For: Mar 31 | SEC filing · Form 10-Q | -3.35% | -8.98% | |
| Form 10-K/A Aurinia Pharmaceuticals For: Dec 31 | SEC filing · Form 10-K | +0.49% | -0.20% | |
| Form 10-K Aurinia Pharmaceuticals For: Dec 31 | SEC filing · Form 10-K | +0.08% | +1.35% | |
| Form 10-Q Aurinia Pharmaceuticals For: Sep 30 | SEC filing · Form 10-Q | +2.78% | +4.23% |
Keep exploring
More AUPH: analyst actions → · SEC filings → · AUPH overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| TETRALOGIC PHARMS CORP (TLOG) | 226 | +0.20% | 52% |
| Y-mAbs Therapeutics, Inc. (YMAB) | 226 | -0.20% | 39% |
| Cel-Sci Corporation (CVM) | 224 | -0.54% | 37% |
| OraSure Technologies, Inc. (OSUR) | 224 | -0.17% | 45% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.